-- "Comparison of blood pressure volatility between conventional and
short daily hemodialysis." Miho Murashima presents on behalf of his
colleagues from the Hospital of the University of Pennsylvania that not
only does daily dialysis reduce blood pressure and the requirement for
antihypertensive medications versus conventional thrice-weekly dialysis,
but it also reduces the relative risk of intradialytic hypotensive
episodes by 86% (TH-PO604, 11/6, 10:00 AM).
-- "Differences in Hemodynamic Parameters and CV Markers between
Patients Undergoing Thrice Weekly or More Frequent HD." Bhupinder
Virk of Satellite Healthcare concludes that home daily hemodialysis
patients appear to have less volume overload and less evidence for
myocardial injury based upon significant reductions in cardiovascular
(CV) markers Troponin T (cTnT) and proBNP in the home daily dialysis
group vs. a matched conventional in-center dialysis cohort (F-PO1706,
11/7, 10:00 AM).
-- "Calcium mass balance during short daily home hemodialysis with a
3.0 mEq/L calcium dialysate." Brent Miller of Washington
University in St. Louis presents that hemodialysis using an average of
approximately 24 L/session of dialysate with a calcium concentration of
3.0 mEq/L with the NxStage System One yields a net calcium balance of
-54 mg per treatment at usual prescribed parameters (SA-PO2691, 11/8,
-- "Recovery of renal function noted in a short daily low volume home
dialysis program." Michael Kraus of Indiana University reports that
6 of 111 daily hemodialysis patients have regained kidney function, a
rate higher than that reported by the USRDS (PUB387).
-- "Quality of life perception by in-center vs. home dialysis
patients." Eduardo La
|SOURCE NxStage Medical, Inc.|
Copyright©2008 PR Newswire.
All rights reserved